Use App
Trending
News
Earnings
All
DIA
0.23%
SPY
0.37%
QQQ
0.24%
Trending
ASTS
16.16%
GRRR
28.56%
PYPL
16.78%
UAL
1.95%
TSM
0.06%
UNH
2.20%
DELL
10.52%
MCD
1.36%
ELVA
44.36%
ASTX
31.51%
ASTS
16.16%
GRRR
28.56%
PYPL
16.78%
UAL
1.95%
TSM
0.06%
UNH
2.20%
DELL
10.52%
MCD
1.36%
ELVA
44.36%
ASTX
31.51%
Feed
News
Sentiment
Fundamentals
Info
home
Symbol
AACP
news
Exchange:
NASDAQ
·
Updated 12:58 PM EDT
AACP
Apogee Acquisition Corp. - Ordinary Shares - Class A
$9.98
$0.00
(0.00%)
Today
2
2
Mkt Cap
$57.33M
Vol
606.00
News
all
press releases
AbbVie's Costly Apogee Acquisition Has Long-Term Upside: Analyst
AbbVie will acquire Apogee Therapeutics for $10.9 billion, with analyst citing long-term immunology growth despite near-term dilution.read more...
Benzinga
<
...
1
>
Advertisement
|
Remove ads.
Latest AACP News
View
AbbVie's Costly Apogee Acquisition Has Long-Term Upside: Analyst
Benzinga
Loading...
Top Discussions
top
active
trending
Advertisement
|
Remove ads.
Advertisement
|
Remove ads.
Watchlist
Trending
News
Explore
Community
Profile